GSK has announced a 50/50 joint venture with leading Indian vaccines company, Biological E, for the early stage research and development of a six-in-one combination paediatric vaccine to help ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

Among them, the cardiac, anti-diabetic, and gastrointestinal therapies saw high value growth of 10.9 per cent, 10.2 per cent, ...

The photos show migrants from Mexico, Guatemala, Honduras, El Salvador and Cuba in the process of being deported. They don't show Indian migrants. But the images in the Facebook post don't show ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...

Trials in China usually recruit patients faster than in the west because of the country’s large pool of people who have not ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of ... with regional and sales hubs across India. The Company is engaged interalia in the business of manufacturing distributing and trading in ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...

NEW DELHI (ANI) – In his farewell message, Eric Garcetti, the outgoing US Ambassador to India, reflected on the ... Shah Rukh Khan’s Om Shanti Om: “Picture abhi baaki hai mere dost!” ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...